These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1420497)

  • 41. One year experience with subcutaneous human erythropoietin in CAPD: correction of renal anemia and increased ultrafiltration.
    Lubrich-Birkner I; Schollmeyer P; Steinhauer HB
    Adv Perit Dial; 1990; 6():302-7. PubMed ID: 1982833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Darbepoetin alfa administered every other week maintains hemoglobin levels over 52 weeks in patients with chronic kidney disease converting from once-weekly recombinant human erythropoietin: results from simplify the treatment of anemia with Aranesp (STAAR).
    Hertel J; Locay H; Scarlata D; Jackson L; Prathikanti R; Audhya P
    Am J Nephrol; 2006; 26(2):149-56. PubMed ID: 16636531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recombinant human erythropoietin in patients on peritoneal dialysis.
    Bargman J
    Perit Dial Int; 1989; 9(4):245-6. PubMed ID: 2488375
    [No Abstract]   [Full Text] [Related]  

  • 44. Pharmacokinetics of recombinant human erythropoietin in children treated with continuous ambulatory peritoneal dialysis.
    Reddingius RE; Schröder CH; Koster AM; Monnens LA
    Eur J Pediatr; 1994 Nov; 153(11):850-4. PubMed ID: 7843202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxidative stress, inflammation and nutritional status during darbepoetin alpha treatment in peritoneal dialysis patients.
    Malgorzewicz S; Lichodziejewska-Niemierko M; Lizakowski S; Liberek T; Lysiak-Szydlowska W; Rutkowski B
    Clin Nephrol; 2010 Mar; 73(3):210-5. PubMed ID: 20178720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing capd.
    Tokgöz B; Utaş C; Doğukan A; Oymak O; Keleştimur F
    Ren Fail; 2002 May; 24(3):315-23. PubMed ID: 12166698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correction of anemia using self-administered daily subcutaneous erythropoietin in uremic patients on continuous ambulatory peritoneal dialysis.
    Li PK; Leung CB; Lui SF; Leung JC; Shek AC; Lai KN
    Int J Artif Organs; 1993 Jul; 16(7):510-4. PubMed ID: 8370605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
    Case DC; Bukowski RM; Carey RW; Fishkin EH; Henry DH; Jacobson RJ; Jones SE; Keller AM; Kugler JW; Nichols CR
    J Natl Cancer Inst; 1993 May; 85(10):801-6. PubMed ID: 8487324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Weekly subcutaneous recombinant human erythropoietin corrects anemia of progressive renal failure.
    Zappacosta AR; Perras ST; Bell A
    Am J Med; 1991 Sep; 91(3):229-32. PubMed ID: 1892142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erythropoietin with oral iron in peritoneal and hemodialysis patients. A comparison in an inner city population.
    Raja R; Bloom E; Goldstein M; Johnson R
    ASAIO J; 1993; 39(3):M578-80. PubMed ID: 8268603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of once- versus thrice-weekly subcutaneous recombinant human erythropoietin in children receiving continuous cycling peritoneal dialysis.
    Ongkingco JR; Ruley EJ; Turner ME; Fragale MR
    Am J Nephrol; 1994; 14(1):14-8. PubMed ID: 8017476
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of recombinant erythropoietin on the early hematocrit rise after CAPD initiation.
    Golper TA
    Perit Dial Int; 1992; 12(1):37-9. PubMed ID: 1543778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of proinflammatory cytokine gene and angiotensin-converting enzyme polymorphisms on erythropoietin requirements in patients on continuous ambulatory peritoneal dialysis.
    Sharples EJ; Varagunam M; Sinnott PJ; McCloskey DJ; Raftery MJ; Yaqoob MM
    Perit Dial Int; 2006; 26(1):64-8. PubMed ID: 16538877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response of continuous peritoneal dialysis patients to subcutaneous recombinant human erythropoietin differs from that of hemodialysis patients.
    Besarab A; Golper TA
    ASAIO Trans; 1991; 37(3):M395-6. PubMed ID: 1751205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A trial of subcutaneous administration of darbepoetin alfa once every other week for the treatment of anemia in peritoneal dialysis patients.
    Mahajan S; Boulton H; Gokal R
    J Nephrol; 2004; 17(5):687-92. PubMed ID: 15593036
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subcutaneous administration of darbepoetin alfa effectively maintains hemoglobin concentrations at extended dose intervals in peritoneal dialysis patients.
    Fang YW; Chang CH
    Perit Dial Int; 2009; 29(2):199-203. PubMed ID: 19293358
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients.
    Brunkhorst R; Bommer J; Braun J; Haag-Weber M; Gill C; Wagner J; Wagener T;
    Nephrol Dial Transplant; 2004 May; 19(5):1224-30. PubMed ID: 14993489
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients.
    Vanrenterghem Y; Bárány P; Mann JF; Kerr PG; Wilson J; Baker NF; Gray SJ;
    Kidney Int; 2002 Dec; 62(6):2167-75. PubMed ID: 12427142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.
    Bunke M; Bartlett DK; Brier ME; Golper TA
    Adv Perit Dial; 1993; 9():331-5. PubMed ID: 8105957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anemia of renal failure. Use of erythropoietin.
    Humphries JE
    Med Clin North Am; 1992 May; 76(3):711-25. PubMed ID: 1578966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.